A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Sargsyan, Siranush A ^a   Blackburn, Daniel J ^b   Barber, Siân C ^b   Grosskreutz, Julian ^c   De Vos, Kurt J ^d   Monk, Peter N ^b   Shaw, Pamela J ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CALCIUM; CELL ADHESION MOLECULE; COPPER ZINC SUPEROXIDE DISMUTASE; NEUROPROTECTIVE AGENT; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; IN VITRO STUDY; MICROGLIA; MOUSE; NERVE CELL; NEUROPROTECTION; NEWBORN; NONHUMAN; PHAGOCYTOSIS; TRANSGENICS; ANIMAL; BIOSYNTHESIS; CELL CYCLE G0 PHASE; CELL MOTION; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; MUTATION; NERVE CELL INHIBITION; PATHOLOGY; PHYSIOLOGY; PRIMARY CELL CULTURE; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CELL MOVEMENT; G0 PHASE; HOMEOSTASIS; HUMANS; MICE; MICE, TRANSGENIC; MICROGLIA; MUTATION; NEURAL INHIBITION; NEUROPROTECTIVE AGENTS; PHAGOCYTOSIS; PRIMARY CELL CULTURE; SUPEROXIDE DISMUTASE;

EID: 80053174167     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-91     Document Type: Article

References (70)

1. Brownell B, Oppenheimer D, Hughes J. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970, 33:338-357. 10.1136/jnnp.33.3.338, 493478, 5431724.
2. Rowland L. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998, 160(Suppl 1):S6-24.
3. Shaw P. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry 2005, 76:1046-1057. 10.1136/jnnp.2004.048652, 1739758, 16024877.
4. Bruijn L, Miller T, Cleveland D. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004, 27:723-749. 10.1146/annurev.neuro.27.070203.144244, 15217349.
5. Rosen D, Siddique T, Patterson D, Figlewicz D, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan J, Deng H. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62. 10.1038/362059a0, 8446170.
6. Andersen P, Nilsson P, Keränen M, Forsgren L, Hägglund J, Karlsborg M, Ronnevi L, Gredal O, Marklund S. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997, 120(Pt 10):1723-1737.
7. Haverkamp L, Appel V, Appel S. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995, 118(Pt 3):707-719.
8. Bruijn L, Becher M, Lee M, Anderson K, Jenkins N, Copeland N, Sisodia S, Rothstein J, Borchelt D, Price D, Cleveland D. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18:327-338. 10.1016/S0896-6273(00)80272-X, 9052802.
9. Gurney M, Pu H, Chiu A, Dal Canto M, Polchow C, Alexander D, Caliendo J, Hentati A, Kwon Y, Deng H. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775. 10.1126/science.8209258, 8209258.
10. Wong P, Borchelt D. Motor neuron disease caused by mutations in superoxide dismutase 1. Curr Opin Neurol 1995, 8:294-301. 10.1097/00019052-199508000-00008, 7582045.
11. Clement A, Nguyen M, Roberts E, Garcia M, Boillée S, Rule M, McMahon A, Doucette W, Siwek D, Ferrante R, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302:113-117. 10.1126/science.1086071, 14526083.
12. Boillée S, Yamanaka K, Lobsiger C, Copeland N, Jenkins N, Kassiotis G, Kollias G, Cleveland D. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392. 10.1126/science.1123511, 16741123.
13. Beers D, Henkel J, Xiao Q, Zhao W, Wang J, Yen A, Siklos L, McKercher S, Appel S. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2006, 103:16021-16026. 10.1073/pnas.0607423103, 1613228, 17043238.
14. Almer G, Teismann P, Stevic Z, Halaschek-Wiener J, Deecke L, Kostic V, Przedborski S. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 2002, 58:1277-1279.
15. Henkel J, Engelhardt J, Siklós L, Simpson E, Kim S, Pan T, Goodman J, Siddique T, Beers D, Appel S. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004, 55:221-235. 10.1002/ana.10805, 14755726.
16. Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G, Mora G, Camana C, Mazzini L, Bachetti T. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 2000, 287:211-214. 10.1016/S0304-3940(00)01177-0, 10863032.
17. Turner M, Cagnin A, Turkheimer F, Miller C, Shaw C, Brooks D, Leigh P, Banati R. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004, 15:601-609. 10.1016/j.nbd.2003.12.012, 15056468.
18. Troost D, Claessen N, van den Oord J, Swaab D, de Jong J. Neuronophagia in the motor cortex in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1993, 19:390-397. 10.1111/j.1365-2990.1993.tb00459.x, 8278021.
19. Kawamata T, Akiyama H, Yamada T, McGeer P. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992, 140:691-707. 1886170, 1347673.
20. Sekizawa T, Openshaw H, Ohbo K, Sugamura K, Itoyama Y, Niland J. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci 1998, 154:194-199. 10.1016/S0022-510X(97)00228-1, 9562310.
21. Elliott J. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 2001, 95:172-178.
22. Hemmer K, Fransen L, Vanderstichele H, Vanmechelen E, Heuschling P. An in vitro model for the study of microglia-induced neurodegeneration: involvement of nitric oxide and tumor necrosis factor-alpha. Neurochem Int 2001, 38:557-565. 10.1016/S0197-0186(00)00119-4, 11290380.
23. Hensley K, Fedynyshyn J, Ferrell S, Floyd R, Gordon B, Grammas P, Hamdheydari L, Mhatre M, Mou S, Pye Q, et al. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol Dis 2003, 14:74-80. 10.1016/S0969-9961(03)00087-1, 13678668.
24. Weydt P, Yuen E, Ransom B, Möller T. Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 2004, 48:179-182. 10.1002/glia.20062, 15378658.
25. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, Takeuchi H, Doyu M, Sobue G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 2002, 80:158-167. 10.1046/j.0022-3042.2001.00683.x, 11796754.
26. Sargsyan S, Blackburn D, Barber S, Monk P, Shaw P. Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1. Neuroreport 2009, 20:1450-1455. 10.1097/WNR.0b013e328331e8fa, 2889291, 19752764.
27. Almer G, Guégan C, Teismann P, Naini A, Rosoklija G, Hays A, Chen C, Przedborski S. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001, 49:176-185. 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X, 11220737.
28. Drew P, Xu J, Storer P, Chavis J, Racke M. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochem Int 2006, 49:183-189. 10.1016/j.neuint.2006.04.003, 16753239.
29. Kriz J, Nguyen M, Julien J. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2002, 10:268-278. 10.1006/nbdi.2002.0487, 12270689.
30. Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 2002, 13:1067-1070. 10.1097/00001756-200206120-00018, 12060810.
31. Zhu S, Stavrovskaya I, Drozda M, Kim B, Ona V, Li M, Sarang S, Liu A, Hartley D, Wu D, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78. 10.1038/417074a, 11986668.
32. Gurney M, Cutting F, Zhai P, Andrus P, Hall E. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase. Pathol Biol (Paris) 1996, 44:51-56.
33. Ceballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, Javoy-Agid F, Lafon M, Blouin J, Sinet P. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res 1991, 552:198-214. 10.1016/0006-8993(91)90084-9, 1717112.
34. Epstein C, Avraham K, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA 1987, 84:8044-8048. 10.1073/pnas.84.22.8044, 299473, 2960971.
35. Avraham K, Schickler M, Sapoznikov D, Yarom R, Groner Y. Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase. Cell 1988, 54:823-829. 10.1016/S0092-8674(88)91153-1, 2970304.
36. Yarom R, Sapoznikov D, Havivi Y, Avraham K, Schickler M, Groner Y. Premature aging changes in neuromuscular junctions of transgenic mice with an extra human CuZnSOD gene: a model for tongue pathology in Down's syndrome. J Neurol Sci 1988, 88:41-53. 10.1016/0022-510X(88)90204-3, 2976083.
37. Shibata N, Asayama K, Hirano A, Kobayashi M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci 1996, 18:492-498. 10.1159/000111445, 8940623.
38. Deng H, Shi Y, Furukawa Y, Zhai H, Fu R, Liu E, Gorrie G, Khan M, Hung W, Bigio E, et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci USA 2006, 103:7142-7147. 10.1073/pnas.0602046103, 1447523, 16636275.
39. Ezzi S, Urushitani M, Julien J. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem 2007, 102:170-178. 10.1111/j.1471-4159.2007.04531.x, 17394546.
40. Hanisch U, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387-1394. 10.1038/nn1997, 17965659.
41. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318. 10.1126/science.1110647, 15831717.
42. Davalos D, Grutzendler J, Yang G, Kim J, Zuo Y, Jung S, Littman D, Dustin M, Gan W. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005, 8:752-758. 10.1038/nn1472, 15895084.
43. Raivich G, Haas S, Werner A, Klein M, Kloss C, Kreutzberg G. Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J Comp Neurol 1998, 395:342-358. 10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2, 9596528.
44. van Rossum D, Hanisch U. Microglia. Metab Brain Dis 2004, 19:393-411.
45. Capani F, Ellisman M, Martone M. Filamentous actin is concentrated in specific subpopulations of neuronal and glial structures in rat central nervous system. Brain Res 2001, 923:1-11. 10.1016/S0006-8993(01)03189-4, 11743966.
46. Nolte C, Möller T, Walter T, Kettenmann H. Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience 1996, 73:1091-1107. 10.1016/0306-4522(96)00106-6, 8809827.
47. Dibaj P, Steffens H, Zschuntzsch J, Nadrigny F, Schomburg ED, Kirchhoff F, Neusch C. In Vivo Imaging Reveals Distinct Inflammatory Activity of CNS Microglia versus PNS Macrophages in a Mouse Model for ALS. PLoS One 2011, 6:e17910. 10.1371/journal.pone.0017910, 3060882, 21437247.
48. Brakebusch C, Fässler R. beta 1 integrin function in vivo: adhesion, migration and more. Cancer Metastasis Rev 2005, 24:403-411. 10.1007/s10555-005-5132-5, 16258728.
49. Breau M, Pietri T, Eder O, Blanche M, Brakebusch C, Fässler R, Thiery J, Dufour S. Lack of beta1 integrins in enteric neural crest cells leads to a Hirschsprung-like phenotype. Development 2006, 133:1725-1734. 10.1242/dev.02346, 16571628.
50. Leone D, Relvas J, Campos L, Hemmi S, Brakebusch C, Fässler R, Ffrench-Constant C, Suter U. Regulation of neural progenitor proliferation and survival by beta1 integrins. J Cell Sci 2005, 118:2589-2599. 10.1242/jcs.02396, 15928047.
51. Streit W, Kreutzberg G. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 1988, 268:248-263. 10.1002/cne.902680209, 3360987.
52. Pearson H, Payne B, Cunningham T. Microglial invasion and activation in response to naturally occurring neuronal degeneration in the ganglion cell layer of the postnatal cat retina. Brain Res Dev Brain Res 1993, 76:249-255.
53. Thanos S. The Relationship of Microglial Cells to Dying Neurons During Natural Neuronal Cell Death and Axotomy-induced Degeneration of the Rat Retina. Eur J Neurosci 1991, 3:1189-1207. 10.1111/j.1460-9568.1991.tb00054.x, 12106219.
54. Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, Martinez G, Cuervo A, Brown R, Glimcher L. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 2009, 23:2294-2306. 10.1101/gad.1830709, 2758741, 19762508.
55. Hsieh C, Koike M, Spusta S, Niemi E, Yenari M, Nakamura M, Seaman W. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 2009, 109:1144-1156. 10.1111/j.1471-4159.2009.06042.x, 3087597, 19302484.
56. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 2007, 4:e124. 10.1371/journal.pmed.0040124, 1851623, 17425404.
57. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50:413-492.
58. Ohsawa K, Irino Y, Nakamura Y, Akazawa C, Inoue K, Kohsaka S. Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia 2007, 55:604-616. 10.1002/glia.20489, 17299767.
59. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther 2006, 109:210-226. 10.1016/j.pharmthera.2005.07.001, 16169595.
60. Tsuda M, Tozaki-Saitoh H, Inoue K. Pain and purinergic signaling. Brain Res Rev 2010, 63:222-232. 10.1016/j.brainresrev.2009.11.003, 19931560.
61. Lambert C, Ase AR, Seguela P, Antel JP. Distinct migratory and cytokine responses of human microglia and macrophages to ATP. Brain Behav Immun 2010, 24:1241-1248. 10.1016/j.bbi.2010.02.010, 20206681.
62. Inoue K. Purinergic systems in microglia. Cell Mol Life Sci 2008, 65:3074-3080. 10.1007/s00018-008-8210-3, 18563292.
63. McLarnon J. Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J Neurosci Res 2005, 81:349-356. 10.1002/jnr.20475, 15948175.
64. D'Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, Pietrini G, Carrì M, Volonté C. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J Immunol 2009, 183:4648-4656. 10.4049/jimmunol.0901212, 19734218.
65. Saura J, Tusell J, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189. 10.1002/glia.10274, 14603460.
66. Cashman N, Durham H, Blusztajn J, Oda K, Tabira T, Shaw I, Dahrouge S, Antel J. Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 1992, 194:209-221. 10.1002/aja.1001940306, 1467557.
67. Menzies F, Cookson M, Taylor R, Turnbull D, Chrzanowska-Lightowlers Z, Dong L, Figlewicz D, Shaw P. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 2002, 125:1522-1533. 10.1093/brain/awf167, 12077002.
68. Grosskreutz J, Haastert K, Dewil M, Van Damme P, Callewaert G, Robberecht W, Dengler R, Van Den Bosch L. Role of mitochondria in kainate-induced fast Ca2+ transients in cultured spinal motor neurons. Cell Calcium 2007, 42:59-69. 10.1016/j.ceca.2006.11.010, 17241659.
69. Haastert K, Grosskreutz J, Jaeckel M, Laderer C, Bufler J, Grothe C, Claus P. Rat embryonic motoneurons in long-term co-culture with Schwann cells--a system to investigate motoneuron diseases on a cellular level in vitro. J Neurosci Methods 2005, 142:275-284. 10.1016/j.jneumeth.2004.09.003, 15698667.
70. Grynkiewicz G, Poenie M, Tsien R. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.